Uranium Energy's Stock Defies $0.11 Loss on Bet That Hoarding Uranium Will Pay Off

Uranium Energy Corp posts larger-than-expected $0.11/share loss, yet shares rise 9% as investors back its strategy of holding uranium off the spot market. Production ramps up; $800M cash, no debt.

Uranium Energy Corp reported a net loss of $0.11 per share for the third quarter of fiscal 2026 — more than double the $0.03 to $0.05 analysts had penciled in — yet shares surged nearly 9% as investors bought into the company's contrarian strategy. The stock traded at €8.85 on Thursday, recovering from a brutal seven-day selloff that erased almost 30% of its value.

The numbers look grim on the surface. Operating costs jumped 74% year-over-year to roughly $41 million, driven largely by higher spending on mineral properties and the ramp-up of production. Revenue? Zero. The company deliberately kept its physical uranium inventory of about 1.4 million pounds off the spot market, betting that holding supplies tight will amplify gains when prices eventually rise. That unhedged strategy is squeezing near-term liquidity and earnings but management argues it's the best way to maximize future price leverage.

Operational progress offers a counterweight to the red ink. In early April, Uranium Energy kicked off production at its Burke Hollow project in South Texas, the largest new uranium development in the US in over a decade and a cornerstone of its hub-and-spoke model. Meanwhile, the Christensen Ranch facility in Wyoming produced its first uranium concentrate, though at a relatively high cost of roughly $55 per pound, weighed down by delayed regulatory approvals and higher state taxes. Both sites are expected to run at higher rates in the current fourth quarter, giving the market hard data for a potential re-rating.

Financially, the company sits on a sturdy foundation despite the operating loss. It holds nearly $800 million in cash and carries no debt. That war chest has kept analysts broadly bullish. Nine analysts rate the stock a consensus "Moderate Buy," with a mean price target of $17.41 — more than double the current level. The range is wide: HC Wainwright sees $26.75, TD Securities trimmed its target to $21 from $22 but kept a Buy rating, Goldman Sachs sits at $16, and Roth MKM at $17.

The stock has been a wild ride. At €8.85, it still trades about 49% below its 52-week high of €17.34 set in January. The seven-day decline of 27% brought the Relative Strength Index to 33, flirting with oversold territory. Annualized 30-day volatility exceeds 100%, reflecting extreme near-term nervousness. On Thursday, the stock already bounced nearly 6%, suggesting some dip-buying appetite.

Underlying the company's patient approach is a structural demand story. Nuclear energy is gaining momentum as a baseload power source, particularly to meet the massive electricity needs of AI data centers. The US government is building up its strategic uranium reserves to reduce reliance on imports. Whether that translates into sustained spot price gains will determine if Uranium Energy's wait-and-see bet delivers — or continues to pressure its balance sheet.